Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Silver Elephant Announces Closing of C$9.2 Million Bought Deal Public Offering, Including Full Exercise of the Over-Allotment Option
-
Havn Life Sciences Announces $5.46 Million Warrant Exercise
-
Olema Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Olema Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Canaccord Genuity Upgrades Royal Gold (RGLD) to Buy
-
Canaccord Genuity Starts Biodesix (BDSX) at Buy
-
Canaccord Genuity Starts MediaAlpha (MAX) at Buy
-
HIVE Blockchain Has Entered into an Agreement to Buy GPU.Ones New 50 MW Campus of Data Centres in New Brunswick
-
VitalHub Selected to Present at the Canaccord Genuity Virtual Health and Wellness Conference
-
Legacy Acquisition Corp. and Onyx Enterprises Int’l Corp. Complete Business Combination
-
BigCommerce Announces Exercise in Full of the Over-Allotment Option in Follow-on Public Offering
-
Grande West Closes Final Tranche of $843,000 for Total Oversubscribed Raise of $8,659,118
-
Maxar Technologies to Participate in Upcoming Investor Conferences
-
Stoke Therapeutics Inc. (STOK) Prices 2.5M Share Common Offering at $39/Sh
-
Stoke Therapeutics Announces Pricing of $97.5 Million Public Offering
-
Dynatronics Corporation Participates in Canaccord Genuity 2020 Medical Technologies & Diagnostics Forum
-
Tantalus Set to Merge with TSX Venture Exchange-listed RiseTech, Enters into Definitive Agreements and Closes Concurrent Financing
-
Gold Bull Announces Closing of C$13.8 Million Financing
-
Olema Pharmaceuticals (OLMA) IPO Opens 137% Higher
-
CB2 Insights Announces Closing of Bought Deal Financing
-
Pre-Open Stock Movers 11/19: (FENT) (APVO) (SONO) Higher; (MGTX) (GPRO) (CUB) Lower (more...)
-
Canaccord Genuity Downgrades Cubic (CUB) to Hold on CTS Risk and Valuation
-
Real Estate & E-Commerce Split Corp. Completes IPO
-
BTIG Investment Banking Division Adds Healthcare Information Technology and Digital Health Specialist Chris Dorn as a Managing Director
-
Jamf Holding Corp. (JAMF) Prices 11M Share Follow-On Offering at $32/Sh by Selling Shareholders
-
Olema Pharmaceuticals Inc. (OLMA) Prices 11M Share IPO at $19/Sh
-
Atalaya Mining PLC Announces Q3 2020 Financial Results
-
Jamf Announces Upsize and Pricing of Follow-on Offering of Common Stock by Selling Shareholders
-
Olema Oncology Announces Pricing of Initial Public Offering
-
Olema Oncology Announces Pricing of Initial Public Offering
-
Stoke Therapeutics Inc. (STOK) Announces 2.5M Share Proposed Public Offering
-
Stoke Therapeutics Announces Proposed Public Offering
-
OnPoint Surgical To Participate In Canaccord Genuity Virtual MedTech & Diagnostics Forum
-
Cardinal Takeover Offers Update
-
Transaction in Own Shares
-
TransGlobe Energy Corporation Announces a Corporate Update
-
Silver Elephant Announces Filing of Technical Report for Pulacayo Project and Final Short-Form Prospectus for Previously Announced $8.0 Million Bought Deal Offering
-
Closed Period Notification
-
Net Asset Value(s)
-
Skeena Resources Closes C$46.0 Million Common Share Public Offering
-
Imperative Care Appoints Matthew Garrett as Chief Financial Officer, Krisztian Toth as Vice President of Finance
-
CloudMD to Present at Upcoming Investor Conferences
-
CI Global Asset Management Files Preliminary Prospectus for CI Galaxy Bitcoin Fund
-
Neovasc to Participate in Canaccord Genuity 2020 Virtual MedTech & Diagnostics Forum
-
Neovasc to Participate in Canaccord Genuity 2020 Virtual MedTech & Diagnostics Forum
-
Meridian Bioscience to Participate in Canaccord Genuity Virtual MedTech & Diagnostics Forum
-
Meridian Bioscience to Participate in Canaccord Genuity Virtual MedTech & Diagnostics Forum
-
Simplify Medical to Present at the 2020 Canaccord Genuity Virtual Medical Technologies & Diagnostics Forum
-
Quanta to Participate in Upcoming Virtual Investor Conferences
-
Canaccord Genuity Reiterates Buy Rating on DraftKings Inc. (DKNG)

